Annual Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
62 |
-5.27 |
29 |
-38 |
-9.91 |
35 |
29 |
33 |
22 |
-34 |
24 |
Consolidated Net Income / (Loss) |
|
74 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Net Income / (Loss) Continuing Operations |
|
65 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Total Pre-Tax Income |
|
65 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Total Revenue |
|
101 |
-2.85 |
53 |
-34 |
-28 |
62 |
49 |
52 |
53 |
-31 |
37 |
Net Interest Income / (Expense) |
|
103 |
-20 |
38 |
-21 |
-77 |
38 |
37 |
37 |
35 |
-19 |
32 |
Total Interest Income |
|
130 |
0.00 |
58 |
0.00 |
-58 |
56 |
55 |
55 |
56 |
0.00 |
54 |
Investment Securities Interest Income |
|
- |
- |
58 |
- |
- |
56 |
55 |
55 |
56 |
- |
54 |
Total Interest Expense |
|
27 |
20 |
20 |
21 |
19 |
18 |
18 |
18 |
21 |
19 |
22 |
Long-Term Debt Interest Expense |
|
- |
20 |
20 |
21 |
19 |
18 |
18 |
18 |
21 |
19 |
22 |
Total Non-Interest Income |
|
-1.99 |
17 |
16 |
-14 |
49 |
24 |
12 |
14 |
18 |
-12 |
5.02 |
Other Service Charges |
|
2.61 |
5.25 |
1.92 |
1.01 |
2.38 |
5.26 |
3.14 |
5.70 |
4.50 |
2.88 |
4.16 |
Net Realized & Unrealized Capital Gains on Investments |
|
-36 |
11 |
-2.03 |
-15 |
62 |
5.17 |
-5.45 |
-2.89 |
0.47 |
-15 |
-12 |
Other Non-Interest Income |
|
- |
- |
16 |
- |
- |
14 |
14 |
11 |
13 |
- |
13 |
Total Non-Interest Expense |
|
34 |
2.41 |
16 |
3.18 |
-11 |
22 |
22 |
20 |
19 |
3.46 |
19 |
Insurance Policy Acquisition Costs |
|
- |
- |
4.01 |
- |
- |
9.23 |
7.92 |
7.02 |
4.70 |
- |
5.45 |
Other Operating Expenses |
|
30 |
2.41 |
12 |
3.18 |
-6.67 |
13 |
14 |
13 |
14 |
3.46 |
13 |
Basic Earnings per Share |
|
$0.67 |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Diluted Earnings per Share |
|
- |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Basic & Diluted Earnings per Share |
|
- |
- |
- |
- |
- |
- |
$0.51 |
- |
- |
- |
$0.47 |
Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
Annual Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
|
13 |
127 |
-79 |
-12 |
-13 |
Net Cash From Operating Activities |
|
89 |
266 |
-317 |
219 |
-27 |
Net Cash From Continuing Operating Activities |
|
89 |
266 |
-317 |
218 |
-27 |
Net Income / (Loss) Continuing Operations |
|
8.28 |
120 |
105 |
123 |
119 |
Consolidated Net Income / (Loss) |
|
8.28 |
120 |
105 |
123 |
119 |
Amortization Expense |
|
-3.23 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
Non-Cash Adjustments to Reconcile Net Income |
|
78 |
167 |
-393 |
110 |
-125 |
Changes in Operating Assets and Liabilities, net |
|
-22 |
-21 |
-28 |
-14 |
-21 |
Net Cash From Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Cash From Continuing Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Cash From Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
Net Cash From Continuing Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
Issuance of Debt |
|
597 |
1,425 |
793 |
348 |
867 |
Repayment of Debt |
|
-716 |
-1,476 |
-467 |
-480 |
-738 |
Payment of Dividends |
|
-86 |
-88 |
-88 |
-99 |
-114 |
Cash Interest Paid |
|
68 |
47 |
43 |
75 |
70 |
Cash Income Taxes Paid |
|
0.00 |
0.24 |
0.13 |
1.22 |
2.25 |
Quarterly Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Net Change in Cash & Equivalents |
|
66 |
-44 |
48 |
-22 |
6.57 |
10 |
-24 |
-39 |
40 |
-5.29 |
78 |
Net Cash From Operating Activities |
|
63 |
-43 |
-8.77 |
122 |
149 |
-64 |
192 |
-136 |
-20 |
-7.27 |
0.65 |
Net Cash From Continuing Operating Activities |
|
63 |
-43 |
-8.77 |
122 |
148 |
-64 |
193 |
-136 |
-20 |
-7.27 |
0.65 |
Net Income / (Loss) Continuing Operations |
|
44 |
29 |
29 |
34 |
31 |
35 |
29 |
33 |
22 |
29 |
24 |
Consolidated Net Income / (Loss) |
|
44 |
29 |
29 |
34 |
31 |
35 |
29 |
33 |
22 |
29 |
24 |
Amortization Expense |
|
-0.30 |
-0.90 |
-0.49 |
-0.37 |
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
Non-Cash Adjustments to Reconcile Net Income |
|
36 |
-72 |
-27 |
90 |
119 |
-102 |
174 |
-161 |
-34 |
-49 |
-6.65 |
Changes in Operating Assets and Liabilities, net |
|
-16 |
0.63 |
-10 |
-1.09 |
-2.76 |
3.49 |
-11 |
-7.48 |
-7.87 |
14 |
-16 |
Net Cash From Financing Activities |
|
2.79 |
-1.24 |
56 |
-145 |
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
Net Cash From Continuing Financing Activities |
|
2.79 |
-1.24 |
56 |
-145 |
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
Issuance of Debt |
|
65 |
155 |
153 |
20 |
20 |
198 |
99 |
268 |
302 |
459 |
300 |
Repayment of Debt |
|
-40 |
-133 |
-72 |
-140 |
-135 |
-97 |
-286 |
-142 |
-213 |
-404 |
-193 |
Payment of Dividends |
|
-22 |
-23 |
-25 |
-25 |
-27 |
-27 |
-29 |
-29 |
-29 |
-58 |
-29 |
Cash Interest Paid |
|
13 |
17 |
18 |
21 |
20 |
18 |
18 |
16 |
19 |
20 |
18 |
Annual Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2021 |
2022 |
2023 |
2024 |
Total Assets |
2,571 |
2,592 |
2,472 |
2,632 |
Cash and Due from Banks |
117 |
30 |
43 |
52 |
Restricted Cash |
86 |
66 |
63 |
46 |
Trading Account Securities |
5.32 |
0.06 |
0.00 |
2,436 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
0.00 |
Other Assets |
77 |
100 |
2,351 |
83 |
Total Liabilities & Shareholders' Equity |
2,571 |
2,592 |
2,472 |
2,632 |
Total Liabilities |
1,471 |
1,476 |
1,336 |
1,492 |
Accrued Interest Payable |
7.06 |
12 |
13 |
14 |
Other Short-Term Payables |
- |
- |
- |
15 |
Long-Term Debt |
1,415 |
1,385 |
1,256 |
1,390 |
Other Long-Term Liabilities |
49 |
79 |
48 |
60 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
1,100 |
1,116 |
1,136 |
1,140 |
Total Preferred & Common Equity |
1,100 |
1,116 |
1,136 |
1,140 |
Total Common Equity |
1,168 |
1,116 |
1,136 |
1,140 |
Common Stock |
1,168 |
1,168 |
1,168 |
1,160 |
Retained Earnings |
- |
-52 |
-32 |
-20 |
Quarterly Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Total Assets |
|
4.53 |
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
Cash and Due from Banks |
|
- |
23 |
88 |
65 |
47 |
18 |
25 |
10 |
28 |
Restricted Cash |
|
- |
51 |
36 |
26 |
74 |
67 |
29 |
56 |
137 |
Trading Account Securities |
|
- |
1.11 |
0.06 |
5.85 |
0.92 |
0.65 |
- |
1.47 |
0.00 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Deferred Acquisition Cost |
|
- |
3.51 |
3.28 |
3.04 |
2.57 |
5.12 |
4.86 |
4.33 |
4.07 |
Other Assets |
|
4.53 |
125 |
161 |
2,443 |
2,449 |
91 |
77 |
2,509 |
105 |
Total Liabilities & Shareholders' Equity |
|
0.00 |
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
Total Liabilities |
|
0.00 |
1,485 |
1,550 |
1,434 |
1,438 |
1,272 |
1,397 |
1,498 |
1,635 |
Accrued Interest Payable |
|
- |
14 |
16 |
15 |
13 |
12 |
13 |
12 |
14 |
Long-Term Debt |
|
- |
1,408 |
1,490 |
1,370 |
1,358 |
1,174 |
1,301 |
1,451 |
1,563 |
Other Long-Term Liabilities |
|
- |
63 |
44 |
42 |
49 |
87 |
83 |
25 |
59 |
Commitments & Contingencies |
|
- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
|
0.00 |
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Total Preferred & Common Equity |
|
0.00 |
1,121 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Total Common Equity |
|
0.00 |
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Common Stock |
|
- |
1,168 |
1,168 |
1,168 |
1,165 |
1,165 |
1,165 |
1,164 |
1,164 |
Retained Earnings |
|
- |
- |
-43 |
-36 |
-23 |
-23 |
-19 |
-20 |
-25 |
Annual Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
Growth Metrics |
|
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
481.63% |
13.00% |
-106.66% |
1,854.77% |
EBITDA Growth |
|
0.00% |
563.96% |
13.26% |
-121.30% |
617.59% |
EBIT Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
NOPAT Growth |
|
0.00% |
415.72% |
14.31% |
-113.75% |
901.54% |
Net Income Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
EPS Growth |
|
0.00% |
1,228.57% |
-12.37% |
17.18% |
-3.14% |
Operating Cash Flow Growth |
|
0.00% |
196.98% |
-219.31% |
169.21% |
-112.36% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
105.52% |
-30.24% |
-105.97% |
Invested Capital Growth |
|
0.00% |
0.00% |
-0.53% |
-4.37% |
5.75% |
Revenue Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-110.47% |
60.59% |
EBITDA Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-142.75% |
64.46% |
EBIT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-138.44% |
64.43% |
NOPAT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-127.93% |
64.43% |
Net Income Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-134.37% |
64.43% |
EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.50% |
Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
-1.95% |
64.08% |
-119.14% |
Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-104.08% |
Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-4.41% |
3.38% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
EBITDA Margin |
|
0.00% |
64.28% |
64.42% |
0.00% |
60.79% |
EBIT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Profit (Net Income) Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
10.72% |
6.03% |
0.00% |
6.24% |
Return on Equity (ROE) |
|
0.00% |
19.05% |
10.81% |
-2.09% |
11.60% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
-191.67% |
5.30% |
3.79% |
-0.23% |
Operating Return on Assets (OROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
Return on Assets (ROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
Return on Common Equity (ROCE) |
|
0.00% |
20.23% |
11.14% |
-2.09% |
11.60% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.52% |
10.73% |
-2.07% |
11.58% |
Net Operating Profit after Tax (NOPAT) |
|
-33 |
105 |
120 |
-16 |
132 |
NOPAT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
0.00% |
0.53% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
0.00% |
35.76% |
35.01% |
0.00% |
38.69% |
Earnings before Interest and Taxes (EBIT) |
|
-47 |
105 |
120 |
-24 |
132 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-23 |
105 |
119 |
-25 |
131 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
3.25 |
0.00 |
5.11 |
Price to Earnings (P/E) |
|
0.00 |
0.00 |
5.68 |
0.00 |
9.22 |
Dividend Yield |
|
18.31% |
12.71% |
14.88% |
12.15% |
8.09% |
Earnings Yield |
|
0.00% |
0.00% |
17.62% |
0.00% |
10.85% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.75 |
0.84 |
0.95 |
Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
10.24 |
0.00 |
11.12 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
15.90 |
0.00 |
18.29 |
Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
9.12 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
14.19 |
21.54 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
Long-Term Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
Financial Leverage |
|
0.00 |
1.29 |
1.26 |
1.17 |
1.16 |
Leverage Ratio |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
Compound Leverage Factor |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
-2.72% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
0.00% |
46.46% |
44.63% |
47.50% |
45.05% |
Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
Net Debt to EBITDA |
|
0.00 |
11.56 |
10.86 |
-45.47 |
9.88 |
Long-Term Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
Net Debt to NOPAT |
|
0.00 |
11.56 |
10.76 |
-69.82 |
9.80 |
Long-Term Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
-6.22% |
-3.09% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,410 |
133 |
93 |
-5.54 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-46.94 |
2.54 |
1.16 |
-0.07 |
Operating Cash Flow to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
Operating Cash Flow Less CapEx to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
Asset Turnover |
|
0.00 |
0.06 |
0.07 |
0.00 |
0.08 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
Invested Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
Invested Capital Turnover |
|
0.00 |
0.13 |
0.07 |
0.00 |
0.09 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
2,515 |
-13 |
-109 |
138 |
Enterprise Value (EV) |
|
0.00 |
0.00 |
1,888 |
2,000 |
2,394 |
Market Capitalization |
|
0.00 |
0.00 |
599 |
850 |
1,101 |
Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
Tangible Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
Total Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
Total Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Total Long-Term Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Net Debt |
|
0.00 |
1,211 |
1,289 |
1,150 |
1,293 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Nonoperating Expense (NNE) |
|
14 |
0.00 |
0.00 |
7.06 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Total Depreciation and Amortization (D&A) |
|
25 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.61M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
-33 |
73 |
84 |
-16 |
92 |
Normalized NOPAT Margin |
|
0.00% |
44.97% |
45.49% |
0.00% |
42.92% |
Pre Tax Income Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
NOPAT to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
EBIT Less CapEx to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
NOPAT Less CapEx to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
Payout Ratios |
|
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
Augmented Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
Quarterly Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
-119.86% |
6.58% |
-282.04% |
-127.99% |
2,261.24% |
-7.60% |
250.07% |
287.08% |
-149.90% |
-23.74% |
EBITDA Growth |
|
0.00% |
-151.19% |
49.83% |
-343.27% |
-126.38% |
725.68% |
-24.26% |
182.02% |
291.05% |
-189.79% |
-31.26% |
EBIT Growth |
|
0.00% |
-141.96% |
50.72% |
-340.19% |
-126.25% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
NOPAT Growth |
|
0.00% |
-129.37% |
38.07% |
-268.14% |
-119.01% |
1,161.57% |
-25.00% |
218.44% |
376.50% |
-161.20% |
-31.67% |
Net Income Growth |
|
0.00% |
-141.96% |
114.09% |
-340.19% |
-123.70% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
EPS Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
22.22% |
0.00% |
-1.92% |
-30.61% |
-20.00% |
-17.78% |
Operating Cash Flow Growth |
|
-8.75% |
57.78% |
95.08% |
222.69% |
135.81% |
-48.26% |
2,293.15% |
-211.07% |
-113.44% |
88.59% |
-99.66% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
0.00% |
-22,845.60% |
0.00% |
102.69% |
112.66% |
103.43% |
-206.68% |
-275.51% |
-212.17% |
Invested Capital Growth |
|
0.00% |
0.00% |
0.00% |
55,210.25% |
-4.37% |
-1.15% |
-11.43% |
-2.22% |
5.75% |
3.82% |
16.63% |
Revenue Q/Q Growth |
|
435.79% |
-102.82% |
1,967.06% |
-164.54% |
17.63% |
317.76% |
-20.17% |
4.81% |
2.68% |
-158.09% |
221.88% |
EBITDA Q/Q Growth |
|
328.84% |
-109.22% |
690.83% |
-204.12% |
53.50% |
318.71% |
-28.48% |
12.76% |
8.32% |
-202.79% |
154.68% |
EBIT Q/Q Growth |
|
329.56% |
-107.84% |
800.59% |
-201.74% |
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
NOPAT Q/Q Growth |
|
315.22% |
-105.68% |
1,100.84% |
-171.22% |
53.05% |
417.20% |
-29.29% |
12.48% |
9.61% |
-170.21% |
178.82% |
Net Income Q/Q Growth |
|
375.93% |
-107.08% |
800.59% |
-201.74% |
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
15.56% |
-5.77% |
12.24% |
-18.18% |
13.33% |
-33.33% |
29.41% |
-15.91% |
Operating Cash Flow Q/Q Growth |
|
163.25% |
-168.13% |
79.58% |
1,494.01% |
21.56% |
-142.83% |
402.14% |
-170.60% |
85.29% |
63.63% |
108.89% |
Free Cash Flow Firm Q/Q Growth |
|
-100.00% |
0.00% |
-1.81% |
2.09% |
103.84% |
-29.74% |
379.39% |
-73.45% |
-219.30% |
-15.58% |
-206.34% |
Invested Capital Q/Q Growth |
|
55,186.06% |
1.10% |
3.41% |
-4.31% |
-4.41% |
4.50% |
-7.34% |
5.64% |
3.38% |
2.60% |
4.08% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
66.08% |
0.00% |
68.38% |
0.00% |
0.00% |
62.56% |
56.05% |
60.30% |
63.61% |
0.00% |
50.50% |
EBIT Margin |
|
66.38% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Profit (Net Income) Margin |
|
73.54% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Tax Burden Percent |
|
114.62% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Interest Burden Percent |
|
96.66% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
4.73% |
0.00% |
9.03% |
0.00% |
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
5.41% |
0.00% |
9.03% |
0.00% |
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
Return on Net Nonoperating Assets (RNNOA) |
|
6.71% |
0.00% |
11.94% |
0.00% |
0.00% |
1.55% |
1.29% |
3.83% |
6.55% |
0.00% |
2.68% |
Return on Equity (ROE) |
|
11.44% |
0.00% |
20.97% |
0.00% |
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
Cash Return on Invested Capital (CROIC) |
|
5.32% |
0.00% |
0.00% |
0.00% |
3.79% |
1.98% |
12.59% |
5.49% |
-0.23% |
-1.45% |
-13.36% |
Operating Return on Assets (OROA) |
|
4.74% |
0.00% |
4.41% |
0.00% |
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
Return on Assets (ROA) |
|
5.25% |
0.00% |
4.41% |
0.00% |
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
Return on Common Equity (ROCE) |
|
11.79% |
0.00% |
20.97% |
0.00% |
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.09% |
10.80% |
6.04% |
0.00% |
1.83% |
1.02% |
7.00% |
0.00% |
5.13% |
4.38% |
Net Operating Profit after Tax (NOPAT) |
|
65 |
-3.69 |
37 |
-26 |
-12 |
39 |
28 |
31 |
34 |
-24 |
19 |
NOPAT Margin |
|
64.16% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Net Nonoperating Expense Percent (NNEP) |
|
-0.68% |
0.23% |
0.00% |
1.64% |
0.40% |
0.00% |
0.00% |
0.00% |
0.00% |
0.73% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
33.62% |
0.00% |
30.70% |
0.00% |
0.00% |
36.50% |
43.76% |
39.65% |
35.58% |
0.00% |
49.64% |
Earnings before Interest and Taxes (EBIT) |
|
67 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
67 |
-6.16 |
36 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-35 |
19 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.54 |
0.53 |
0.64 |
0.74 |
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
Price to Tangible Book Value (P/TBV) |
|
0.54 |
0.53 |
0.64 |
0.74 |
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
Price to Revenue (P/Rev) |
|
3.25 |
3.71 |
4.24 |
7.17 |
0.00 |
17.43 |
20.20 |
7.58 |
5.11 |
8.73 |
8.77 |
Price to Earnings (P/E) |
|
5.68 |
7.06 |
7.09 |
17.26 |
0.00 |
54.06 |
58.06 |
11.63 |
9.22 |
21.40 |
21.80 |
Dividend Yield |
|
14.88% |
14.81% |
13.06% |
11.83% |
12.15% |
8.87% |
8.76% |
8.57% |
8.09% |
11.02% |
14.96% |
Earnings Yield |
|
17.62% |
14.16% |
14.11% |
5.80% |
0.00% |
1.85% |
1.72% |
8.59% |
10.85% |
4.67% |
4.59% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.75 |
0.77 |
0.80 |
0.85 |
0.84 |
0.86 |
0.89 |
0.92 |
0.95 |
0.95 |
0.88 |
Enterprise Value to Revenue (EV/Rev) |
|
10.24 |
11.69 |
12.25 |
18.09 |
0.00 |
41.14 |
42.80 |
16.88 |
11.12 |
20.00 |
21.33 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
15.90 |
19.42 |
18.53 |
35.83 |
0.00 |
110.55 |
194.62 |
28.43 |
18.29 |
42.59 |
48.33 |
Enterprise Value to EBIT (EV/EBIT) |
|
15.76 |
19.15 |
18.25 |
34.63 |
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
15.76 |
19.15 |
18.62 |
35.94 |
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
15.86 |
9.12 |
10.82 |
5.16 |
15.98 |
0.00 |
83.83 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
21.54 |
43.07 |
6.64 |
16.65 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
1.24 |
1.21 |
1.32 |
1.21 |
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
Long-Term Debt to Equity |
|
1.24 |
1.21 |
1.32 |
1.21 |
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
Financial Leverage |
|
1.24 |
1.16 |
1.32 |
1.21 |
1.17 |
1.18 |
1.17 |
1.17 |
1.16 |
1.23 |
1.20 |
Leverage Ratio |
|
2.33 |
2.23 |
2.38 |
2.27 |
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
Compound Leverage Factor |
|
2.25 |
2.23 |
2.38 |
2.27 |
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
Debt to Total Capital |
|
55.37% |
54.65% |
56.96% |
54.75% |
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
55.37% |
54.65% |
56.96% |
54.75% |
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
44.63% |
45.35% |
43.04% |
45.25% |
47.50% |
45.70% |
49.32% |
46.85% |
45.05% |
44.09% |
42.16% |
Debt to EBITDA |
|
11.67 |
14.01 |
13.23 |
23.16 |
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
Net Debt to EBITDA |
|
10.86 |
13.26 |
12.12 |
21.62 |
-45.47 |
63.70 |
102.78 |
15.66 |
9.88 |
24.00 |
28.46 |
Long-Term Debt to EBITDA |
|
11.67 |
14.01 |
13.23 |
23.16 |
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
Debt to NOPAT |
|
11.57 |
13.81 |
13.29 |
23.24 |
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
Net Debt to NOPAT |
|
10.76 |
13.08 |
12.18 |
21.69 |
-69.82 |
59.31 |
93.52 |
15.52 |
9.80 |
23.61 |
28.00 |
Long-Term Debt to NOPAT |
|
11.57 |
13.81 |
13.29 |
23.24 |
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
Noncontrolling Interest Sharing Ratio |
|
-3.09% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,533 |
-2,579 |
-2,525 |
97 |
68 |
327 |
87 |
-103 |
-120 |
-366 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-129.55 |
-126.03 |
-121.52 |
5.04 |
3.77 |
18.52 |
4.79 |
-4.95 |
-6.32 |
-16.82 |
Operating Cash Flow to Interest Expense |
|
2.31 |
-2.20 |
-0.43 |
5.89 |
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
Operating Cash Flow Less CapEx to Interest Expense |
|
2.31 |
-2.20 |
-0.43 |
5.89 |
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.07 |
0.06 |
0.06 |
0.09 |
0.00 |
0.02 |
0.02 |
0.05 |
0.08 |
0.05 |
0.04 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
2,502 |
2,529 |
2,615 |
2,503 |
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
Invested Capital Turnover |
|
0.07 |
0.13 |
0.13 |
0.09 |
0.00 |
0.02 |
0.02 |
0.05 |
0.09 |
0.05 |
0.04 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
2,529 |
2,615 |
2,498 |
-109 |
-29 |
-299 |
-56 |
138 |
96 |
385 |
Enterprise Value (EV) |
|
1,888 |
1,953 |
2,087 |
2,119 |
2,000 |
2,147 |
2,061 |
2,263 |
2,394 |
2,458 |
2,373 |
Market Capitalization |
|
599 |
619 |
722 |
840 |
850 |
910 |
973 |
1,017 |
1,101 |
1,073 |
976 |
Book Value per Share |
|
$17.29 |
$18.10 |
$17.44 |
$17.54 |
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
Tangible Book Value per Share |
|
$17.29 |
$18.10 |
$17.44 |
$17.54 |
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
Total Capital |
|
2,502 |
2,576 |
2,615 |
2,503 |
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
Total Debt |
|
1,385 |
1,408 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Total Long-Term Debt |
|
1,385 |
1,408 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Net Debt |
|
1,289 |
1,333 |
1,366 |
1,279 |
1,150 |
1,237 |
1,089 |
1,246 |
1,293 |
1,385 |
1,398 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Nonoperating Expense (NNE) |
|
-9.49 |
1.58 |
0.00 |
11 |
5.29 |
0.00 |
0.00 |
0.00 |
0.00 |
10 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
1,385 |
1,361 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Total Depreciation and Amortization (D&A) |
|
-0.30 |
-0.90 |
-0.49 |
-0.37 |
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.67 |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Adjusted Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.47 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
45 |
-3.69 |
26 |
-26 |
-12 |
27 |
19 |
22 |
24 |
-24 |
13 |
Normalized NOPAT Margin |
|
44.91% |
0.00% |
48.51% |
0.00% |
0.00% |
44.45% |
39.37% |
42.25% |
45.10% |
0.00% |
35.25% |
Pre Tax Income Margin |
|
64.16% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
2.46 |
-0.27 |
1.80 |
-1.81 |
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
NOPAT to Interest Expense |
|
2.38 |
-0.19 |
1.80 |
-1.26 |
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
EBIT Less CapEx to Interest Expense |
|
2.46 |
-0.27 |
1.80 |
-1.81 |
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
NOPAT Less CapEx to Interest Expense |
|
2.38 |
-0.19 |
1.80 |
-1.26 |
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
73.32% |
87.39% |
75.39% |
137.70% |
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
Augmented Payout Ratio |
|
73.32% |
87.39% |
75.39% |
137.70% |
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
Key Financial Trends
Bain Capital Specialty Finance (NYSE: BCSF) demonstrated notable financial trends over the past four years through its quarterly data ending Q2 2025. The company's financials exhibit both growth opportunities and challenges, as highlighted below:
- Consistent positive net income: Bain Capital Specialty Finance reported positive consolidated net income in all quarters of 2023 and 2024, with a rebound from a Q1 2023 loss to steady profits in subsequent quarters. For Q2 2025, net income was $23.7 million, indicating recovery and profitability momentum.
- Increasing total revenue over recent years: Total revenue generally increased from about $49 million in Q2 2023 to approximately $37.5 million in Q2 2025, showing resilience. The net interest income remains a core driver, demonstrating healthy margin generation ($32.5 million net interest income in Q2 2025).
- Strong equity position: Total common equity remained stable around $1.1 billion over recent quarters with moderate fluctuations, reflecting a solid capital base supporting operations and growth.
- Effective debt management: The company issued and repaid significant amounts of long-term debt regularly, with $300 million issued and $193 million repaid in Q2 2025, reflecting active management of leverage and capital structure.
- Volatile non-interest income: Though other non-interest income contributed positively in Q2 2025 ($12.6 million), net realized and unrealized capital losses were sizable (-$11.7 million), indicating investment volatility impacting income.
- Amortization expenses remained low but volatile, with a $50 thousand expense in Q2 2025, generally minor relative to other costs and income.
- Cash and equivalents increased from $23 million in Q1 2023 to $27.8 million in Q2 2025, indicating modest liquidity improvement.
- Operating cash flow volatility: Net cash from operating activities swung from negative $63.7 million in Q1 2024 to a positive $0.65 million in Q2 2025, showing irregular cash generation consistency.
- Net cash from financing activities fluctuated significantly, with large debt issuances and repayments plus dividend payments affecting cash balances each quarter, which may introduce financial strategy uncertainty.
- Retained earnings showed negative values ranging from approximately -$4.3 million to -$25 million in recent quarters, potentially indicating accumulated losses or dividend distributions exceeding net profits, which could impact future capital retention.
In summary, Bain Capital Specialty Finance has shown an improving profitability trend with stable equity and active debt management. However, variability in cash flows, capital gains volatility, and negative retained earnings may warrant investor caution. Monitoring future quarters for consistency in operating cash flow and sustained net income growth will be key for assessing long-term financial health.
08/23/25 02:15 AMAI Generated. May Contain Errors.